Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2

Por um escritor misterioso
Last updated 11 novembro 2024
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
KR100837019B1 - 3-4-heteroarylcyclohexylaminocyclopentanecarboxamides as modulators of chemokine receptors - Google Patents
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties - ScienceDirect
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Selective and Dual Targeting of CCR2 and CCR5 Receptors: A Current Overview
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Sander G Mills's research works Merck & Co., Whitehouse Station (MSD) and other places
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
US7834021B2 - 3-aminopyrrolidine derivatives as modulators of chemokine receptors - Google Patents
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2 (CCR2) Antagonists
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2 (CCR2) Antagonists
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Full article: Future therapeutic treatment of COPD: Struggle between oxidants and cytokines
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Structural Analysis of Chemokine Receptor–Ligand Interactions
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties - ScienceDirect

© 2014-2024 likytut.eu. All rights reserved.